Meta now notching another name and its expensive hunt for AI talent poaching a top Apple executive for reportedly tens of millions of dollars. But is the spending starting to stack up. Dear DOSA digs into that for today's tech check.Hi D. Hey guys, good morning. So Wells Fargo calls it Zuckerberg's Steinbrunner moment.Of course, that's a reference to the Yankees owner who famously spent whatever it took to win, signing the biggest names, writing blank checks, daring anyone to outbid him. Now, that is what Z ...

PRESS RELEASE REGULATED INFORMATION: ONGOING Shares concerned: Carbios (ISIN code: FR0011648716)Market concerned: Euronext Growth Paris Clermont-Ferrand (France), 08 July 2025 (18:00 CEST). CARBIOS, (Euronext Growth Paris: ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastic and textiles, reports today about the liquidity contract entrusted to Natixis ODDO BHF. As of June 30, 2025, the following assets appeared on the liquidity account ...

Solutions30, the European leader in multi-technical field services for the telecommunications, energy, and digital sectors, announces the appointment of Arno Janssen as CEO of its operations in the Netherlands. This appointment follows the recent strengthening of its leadership team, including the nominations of Antoine Mirabel (France), Oliver Fidorra (Germany), and Axel Vandevenne (Belgium).Arno Janssen brings extensive international experience, having held several senior leadership positions at Bosch Bui ...

MILWAUKEE, July 8, 2025 /PRNewswire/ -- The Ademi Firm is investigating CARGO (NASDAQ: CRGX) for possible breaches of fiduciary duty and other violations of law in its transaction with Concentra Biosciences.Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995. There is no cost or obligation to you.In the transaction, shareholders of CARGO will receive $4.379 in cash per share, plus one non-transferable contingent va ...

Key Takeaways COGT soared after its SUMMIT study met all endpoints in non-advanced systemic mastocytosis. Bezuclastinib showed strong symptom reduction and biomarker response versus placebo. The drug was well-tolerated, and an FDA submission is targeted for the end of 2025.Shares of Cogent Biosciences (COGT) soared 23.4% on Monday after the company reported positive top-line data from a late-stage study of its investigational candidate, bezuclastinib, for treating non-advanced systemic mastocytosis (SM) p ...

Core Insights - OneClick Data, Inc. has integrated its building code data with Verisk's Xactware platform, enhancing claims professionals' access to crucial local code information for faster and more accurate claims resolution [1][2][6] - The collaboration aims to eliminate guesswork in property restoration claims, improving efficiency and transparency in the claims ecosystem [4][6] - OneClick Code's database covers over 32,000 municipalities and more than 99% of street addresses in the U.S., significantly outperforming other solutions that may return no results up to 40% of the time [4] Company Overview - OneClick Data, Inc. specializes in automated building code and permit data, providing address-specific reports that enhance transparency and accuracy in the construction and insurance industries [7] - The company has generated over 500,000 building code reports in the past year, showcasing its extensive reach and capability in the market [4] Industry Impact - The integration with Verisk's Xactware suite supports professionals in property insurance, remodeling, and restoration, driving accuracy and efficiency in claims resolution [5] - The upcoming expansion of OneClick Code's offerings will include exterior building code data, further aiding claims professionals in reducing research time and minimizing loss adjustment expenses [3]

Key Takeaways SOFI posted 20% sales growth and a 217% profit jump in Q1 2025, driven by an efficient cost structure. A $2B Fortress loan deal supports SOFI's pivot toward fee-based, less capital-intensive revenue. New credit cards expand SOFI's consumer finance reach and boost long-term customer engagement.SoFi Technologies, Inc. (SOFI) is doubling down on its core strengths — scale and innovation — to drive profitability and maintain momentum in a competitive fintech landscape.In the first quarter of 202 ...

Key Takeaways BAYRY has started a phase I/IIa study of OpCT-001 for primary photoreceptor degenerative diseases. OpCT-001 is the first iPSC-derived cell therapy tested in humans for inherited eye conditions. The CLARICO trial assesses safety, vision impact, and cell engraftment across patient subgroups.Bayer’s (BAYRY) wholly owned subsidiary, BlueRock Therapeutics, announced that the first patient in the phase I/IIa CLARICO study has received OpCT-001, an investigational iPSC-derived cell therapy, which i ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Rocket Pharmaceuticals To Contact Him Directly To Discuss Their OptionsIf you suffered losses exceeding $50,000 in Rocket Pharmaceuticals between February 27, 2025 and May 26, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).[You may also click here for additional information]NEW YOR ...

Key Takeaways FDA accepted DNLI's BLA for tividenofusp alfa in Hunter syndrome, with Priority Review granted. Tividenofusp alfa uses DNLI's TV platform to address both cognitive and physical symptoms of MPS II. A potential approval would be DNLI's first, significantly advancing its move to a commercial biotech.Denali Therapeutics, Inc. (DNLI) announced that the FDA has accepted for review its biologics license application (BLA) for lead-pipeline candidate tividenofusp alfa.The BLA is seeking accelerated a ...